Mounjaro Weight Loss by Week: What Results Can You Expect?

Updated November 2026

There is no fixed amount of weight you should lose each week on Mounjaro. Your response, prescribed dose and wider treatment plan all matter. The first month starts at a low dose, and progress needs to be reviewed over time rather than judged against someone else’s results.

At Everest Pharmacy, we can help you understand your treatment and discuss concerns about your progress. Here’s how to make sense of the weekly timeline without setting yourself an unrealistic target.

On this page: weekly timeline · clinical trial results · tracking progress · nutrition and activity · when to seek advice.

The weekly timeline

Mounjaro contains tirzepatide. It helps reduce appetite and increase fullness, supporting weight management alongside changes to food intake and physical activity. Read the NHS explanation of tirzepatide.

The table below shows the earliest possible dose increases under the licensed adult schedule, assuming each increase is needed, prescribed and tolerated. It is not a plan for everyone to follow.

The starting dose is 2.5 mg weekly for four weeks, followed by 5 mg. Any later increase must be prescribed and follow at least four weeks at the current dose. Follow your own instructions and contact your prescriber if side effects make the next step difficult. See the current patient leaflet.

You do not have to reach 15 mg. The recommended adult maintenance doses are 5 mg, 10 mg and 15 mg; your prescriber chooses an appropriate dose based on your response and tolerability. UK prescribing information, section 4.2.

Weeks 1–4: get to know your response

Use the first month to record how you’re getting on: your appetite, eating, weight and any symptoms. Take questions to your review rather than changing the dose yourself.

There is no evidence-based kilogram target that applies to everyone in these four weeks. A small change on the scales cannot tell you, on its own, what your longer-term response will be.

Weeks 5–12: review the overall pattern

This is a useful time to compare your records with your starting point. Can you manage regular meals? Are side effects interfering with eating or drinking? What does the weight trend show?

You might remain on 5 mg or have a further prescribed increase. Moving through doses faster is not a way to make up for slower progress.

Week 13 onwards: keep the plan individual

There is no universal week when Mounjaro reaches its “full effect”. Your ongoing plan should reflect the benefits you are getting and any problems you are having.

NHS England’s guidance on support during treatment explains that there is no specific expected weight-loss trajectory. Food quality, physical activity and regular clinical reviews remain part of care throughout treatment.

How much weight did people lose in clinical trials?

In the original SURMOUNT-1 trial, 2,539 adults with obesity, or overweight with a weight-related complication, were studied for 72 weeks. Participants did not have diabetes and received lifestyle support alongside tirzepatide or placebo.

These published averages included participants regardless of whether they stopped treatment. They are not guaranteed personal results, and cannot be divided into a weekly forecast. They don’t tell you what you personally will lose after three or six months. The study was funded by Eli Lilly. Read the original trial abstract.

How to track your progress

A consistent routine makes your records easier to compare:

• Agree a weighing frequency with your clinician; weekly may be practical.
• Use the same scales in the same place.
• Put them on a firm, level floor.
• Weigh at a similar time, preferably in the morning.
• Wear similar light clothing each time.

These steps follow NHS England’s advice on recording weight. Keep the readings together so you and your prescriber can review the pattern.

You can calculate percentage weight loss as: weight lost ÷ starting weight × 100. For example, losing 5 kg from a starting weight of 100 kg is 5%. That is a calculation, not a suggested target for your first month.

Make your weekly record useful

Alongside your weight, write down your dose, injection date and a short note about how the week felt. “Eating regular meals, less snacking, nausea on Tuesday” tells your prescriber more than “good week” or “bad week”. You do not need a complicated app; a notebook or a simple phone note is enough.

Keep the starting measurement visible. If you begin at 120 kg and later weigh 114 kg, that is a 6 kg reduction, or 5% of your starting weight. Someone starting at a different weight will reach the same percentage after a different number of kilograms. This is one reason other people’s totals are an unreliable personal target.

Also record what you want treatment to help you do, such as walk more comfortably or manage everyday tasks. These goals give your consultation a practical focus alongside the measurements.

Support your health while losing weight

Keep nutrition in view

A smaller appetite still needs a balanced eating plan. Include protein foods such as eggs, fish, beans, lentils or tofu, alongside a variety of other foods. Protein helps maintain muscle, and weight loss can involve muscle as well as fat. If you have chronic kidney disease, ask your dietitian about a suitable protein target. NHS advice on nutrition with weight-loss medicines.

Bring up practical difficulties early. For example, tell your clinician if you are repeatedly missing meals because you feel too full, or if you need help adapting meals around your budget, preferences or medical conditions. Your food plan should be something you can manage in daily life.

Build activity around your ability

Strength-based activity helps protect muscle during weight loss. Start with manageable movement and build gradually, rather than judging exercise by how many calories a session burns. Ask your GP or physiotherapist for advice before a new routine, especially if you have a health condition, are new to exercise or are experiencing side effects. NHS guidance on staying active during treatment.

Choose a practical goal you can review: a short walk added to your day, for example, or learning suitable strength exercises. Record what you managed and what made it difficult. This gives you something specific to build on at your next appointment.

What happens after you reach your goal?

Agree a maintenance plan with your prescriber. Reaching a particular weight does not automatically tell you whether to continue, change or stop treatment. Discuss ongoing benefits, side effects, your preferences and the support you will need.

Weight regain can happen after stopping, so discuss that possibility before making a change. NICE’s practical guidance recommends continued dietary and activity support when treatment ends. If cost or another concern is making treatment difficult to maintain, raise it at your review so you can discuss a plan.

What if your weight loss slows or stops?

Arrange a review if you are concerned. Useful questions to take with you include:

• How long have I been on this dose?
• Have I missed any injections or had a break in treatment?
• Am I using and storing the pen correctly?
• Are side effects affecting how much I can eat or drink?
• Does my treatment plan need to change?

Your prescriber can help assess the whole picture. NICE advises reviewing whether to continue if less than 5% of starting weight has been lost after six months on the highest tolerated dose, considering individual benefits and risks. This is not an automatic stop at six months from the first injection, and you can ask for help earlier. NICE guidance on weight-management medicines.

Side effects and when to seek help

Nausea, vomiting, diarrhoea and constipation can occur. Tell your prescriber about symptoms that persist or interfere with daily life; do not assume every symptom is something to put up with. NICE’s practical tirzepatide guidance.

• Stop Mounjaro and seek urgent medical help for severe, persistent stomach pain, especially if it spreads to your back, with or without vomiting. This can indicate pancreatitis. MHRA safety advice.
• Call 999 for breathing difficulty or swelling of your tongue or throat, which may indicate a serious allergic reaction. NHS information on anaphylaxis.
• Seek prompt advice if repeated vomiting or diarrhoea leaves you unable to keep fluids down. NICE practical guidance.
• If you use the contraceptive pill, add a barrier method or switch to a non-oral method for four weeks after starting and after each dose increase. Discuss effective cover with a clinician. MHRA contraception advice.
• Do not use Mounjaro during pregnancy. Stop at least one month before a planned pregnancy. If breastfeeding, speak to your doctor before starting or continuing treatment. Current product information, section 4.6.

Frequently asked questions

Mounjaro is a prescription-only medicine. Treatment depends on an individual clinical assessment. This information supports, and does not replace, advice from your prescriber.

Written on behalf of Everest Pharmacy by Pharmacy Mentor.